baber/WOPTO huggingface dataset:
Patent JP-3872236-B2 (JP)
IPC: H05K1/18
Filed: 1999-09-28
Granted: 2007-01-24
Abstract: PROBLEM TO BE SOLVED: To make it possible to keep a wiring board and a semiconductor element package in a stablely connected state to an outer electric circuit (printed board) steadily for a long time. SOLUTION: When a package (A) with a connection electrode 3 is mounted on a printed board (B), on which a connection electrode 11 is provided for connection, a laminated terminal is mounted on the connection electrode 3 of the package (A). The laminated terminal has a laminated body, in which a conductive pillar-shaped body made of metal or resin is laminated with conductive adhesive, and a ratio of H/R, where R is a maximum radius of the laminated body and H is the whole height, is 5 or below.
Patent JP-3658946-B2 (JP)
IPC: H01L23/58
Filed: 1997-10-16
Granted: 2005-06-15
Abstract: PROBLEM TO BE SOLVED: To provide a mounting structure, wherein an induction with rapid change in the current flowing in a main current wiring at switching has no ineffect over the control of a transistor. SOLUTION: A power transistor chip 10 has base electrodes 2 for control signals and at least one group of main electrodes, e.g. emitter electrodes 1 on one main plane having thereon a control signal wiring 12 connected to the base electrodes 2 and main wiring 11 connected to the emitter electrodes 1, such that the control signal wiring 12 is orthogonal to the main wiring 11 for making the current flow on the main wiring 11 orthogonal with respect to that on the control signal wiring 12.
Patent JP-2905525-B2 (JP)
IPC: C22C47/08
Filed: 1989-11-10
Granted: 1999-06-14
Abstract: The present invention relates to the formation of a macrocomposite body by spontaneously infiltrating a permeable mass of filler material or a preform (4) with molten matrix metal (2) and bonding the spontaneously infiltrated material to at least one second material such as a ceramic or ceramic containing body and/or a metal or metal containing body. Particularly, an infiltration enhancer and/or infiltration enhancer precursor and/or infiltrating atmosphere are in communication with a filler material or a preform (4), at least at some point during the process, which permits molten matrix metal (2) to spontaneously infiltrate the filler material or preform (4). Moreover, prior to infiltration, the filler material or preform (4) is placed into contact with at least a portion of a second material such that after infiltration of the filler material or preform (4), the infiltrated material is bonded to the second material, thereby forming a macrocomposite body.
Patent JP-2592473-B2 (JP)
IPC: C08G12/12
Filed: 1987-12-04
Granted: 1997-03-19
Abstract: Urea-aldehyde polycondensates usable as surface coating binders are obtainable by step-wise reaction of (a) urea and/or urea derivatives with acidic CH aldehydes in a molar ratio of urea:aldehyde of 1:2 in the presence of acids and at from 60 DEG  to 120 DEG  C. with (b) a mixture of 3 moles of formaldehyde per mole or urea and 3 moles of an acidic CH aldehyde per mole of urea at from 60 DEG  to 120 DEG  C. with subsequent removal of the water of reaction and treatment of the reaction mixture with an alkali metal alcoholate at from 80 DEG  to 100 DEG  C.
Patent JP-3007105-B2 (JP)
IPC: C09J157/00
Filed: 1989-12-21
Granted: 2000-02-07
Abstract: Polymer compositions comprising a) one or more polymer(s) containing pendant and/or terminal phosphorus groups and b) one or more water-soluble polyvalent metal compounds(s) may be are useful in coatings to give improved solvent resistance, chemical resistance, print resistance, corrosion resistance and/or adhesion to metal.
Patent JP-2839602-B2 (JP)
IPC: C08G65/28
Filed: 1989-12-27
Granted: 1998-12-16
Abstract: The invention relates to the use of adducts of 1,2-butylene oxide to H-acidic organic compounds as lubricants, and to lubricants containing these adducts.
Patent JP-3007252-B2 (JP)
IPC: F27D1/12
Filed: 1993-12-24
Granted: 2000-02-07
Abstract: Means are provided for the replacement of a thermally stressed portion of a unitary water cooled closure element, e.g. made of plain carbon steel, of a furnace system which includes a steel frame to which is pre-welded copper covering plate, the steel frame being welded into a closely fitting cut-out in the closure element, e.g. a furnace roof or furnace shell. <IMAGE>
Patent JP-4320492-B2 (JP)
IPC: H01L25/065
Filed: 1999-12-08
Granted: 2009-08-26
Abstract: PROBLEM TO BE SOLVED: To compactly mount a semiconductor device on a wiring board so as to improve other parts in mounting efficiency. SOLUTION: Interlayer through-electrodes 18 and bump electrodes 19 are formed on a multilayer wiring board that serves as a base, and a semiconductor device 17 is mounted in a flip chip mounting manner, and thermosetting resin is applied thereon, then thermally cured, and ground to set the semiconductor device 17 as thick as prescribed, and an interlayer connection electrode 18 is exposed. A wiring electrode 21 is formed, thermosetting resin is applied thereon, and a multilayer board 13 is placed on the thermosetting resin, and the thermosetting resin is cured as a pressure is applied on the multilayer board 13, and the wiring electrode 21 and the multilayer wring board 13 are electrically connected together. Mounting structures 14 can be laminated in layers so as to be a laminated circuit module.  A surface-mpounting device can be mounted on all the surfaces of the multilayer wiring boards 12 and 13, and a compact laminated circuit module of moderate thickness can be formed.
Patent JP-4016557-B2 (JP)
IPC: H01L21/60
Filed: 1999-12-24
Granted: 2007-12-05
Abstract: PROBLEM TO BE SOLVED: To prevent deterioration of productivity, a thermal effect on another loaded component, generation of a void in a resin and unrepairable manufacturing drawback of a BGA/CSP(ball grid array or chip size package) in a mounting structure in which an electronic component is mounted on a substrate via a solder bump. SOLUTION: A resin sheet 5 obtained by sandwiching both sides of a cured thermosetting resin plate 51 with a pair of thermosetting resin films 52 is previously prepared, and the resin sheet 5 is interposed between a BGA/CSP 2 and a substrate 3. At the same time, reflowing and curing of a solder bump 1 are performed with the solder bump 1 brought into contact with a land portion 4. Subsequently, by heating and pressurizing the solder bump 1 at a lower temperature than the melting temperature of the solder bump 1, the solder bump 1 is crushed and each of both the thermosetting resin films 52 is bonded to the BGA/CSP 2 and the substrate 3.
Patent JP-2686478-B2 (JP)
IPC: F16L55/165
Filed: 1995-06-07
Granted: 1997-12-08
Abstract: A corrugated plastic service pipe 20 is inserted together with a flexible guide assembly 22 through an accessible end 11 of a steel service pipe 14, 10, which extends from the end 11 to a main 18. The flexible guide assembly 22 comprises a flexible guide element 24 and a flexible spring guide 26. The element 24 extends through a nose-piece 32 having an outer part secured to the pipe 20 and an inner part 36. The spring guide 26 carries a sensor 60 at its tip which emits a signal when the sensor enters the main 18. When the pipe 20 is correctly positioned fluid sealant 70 is injected into the space between the pipe 20 and the pipe 14, 10. When the sealant has solidified sufficiently, the guide assembly 22 is withdrawn through the pipe 20, the inner part 36 being separated from the outer part 34 to allow withdrawal of the spring guide 26.
Patent JP-2783296-B2 (JP)
IPC: C12N9/50
Filed: 1989-11-25
Granted: 1998-08-06
Abstract: PCT No. PCT/EP89/01427 Sec. 371 Date May 14, 1991 Sec. 102(e) Date May 14, 1991 PCT Filed Nov. 25, 1989 PCT Pub. No. WO90/06362 PCT Pub. Date Jun. 14, 1990Pure glycosylated, partially glycosylated or unglycosylated polypeptides have the amino-acid sequence of ancrod, in which up to 5 amino acid residues can be replaced by residues of other natural amino acids, and are suitable for controlling diseases.
Patent JP-2681782-B2 (JP)
IPC: H01C1/032
Filed: 1987-02-06
Granted: 1997-11-26
Abstract: A thin film platinum resistance thermometer capable of operation at elevated temperatures includes a benign dielectric layer covering the thin film platinum resistance temperature sensing element and a barrier layer overlying the dielectric layer. The barrier layer, which is preferrably titanium dioxide, resists diffusion of contaminants which would alter the electrical characteristics of the sensing element, while permitting diffusion of oxygen through the barrier layer.
Patent JP-2588267-B2 (JP)
IPC: C07J53/00
Filed: 1988-03-11
Granted: 1997-03-05
Abstract: New 19,11 beta -bridged steroids of the general formula I   <IMAGE> (I)  where R1 stands for a methyl or ethyl radical, R2 for a hydrogen or chlorine atom or a C1-C4-alkyl radical, B and G, which are the same or different, respectively for a hydrogen atom, a C1-C4-alkyl radical or, together, for a second bond between the carbon atoms 6 and 7, B and R2 together for a methylene or an ethylene group, Z for the radical of a pentagonal or hexagonal ring, which is possibly substituted and possibly unsaturated, V stands for a possibly substituted carbocyclic or heterocyclic aryl radical, the ring A for <IMAGE> a)   M and N together meaning a second bond or M a hydrogen atom and N a hydroxy group, X means an oxygen atom, two hydrogen atoms or a hydroxyimino grouping N DIFFERENCE OH, R3 and D, which are the same or different, respectively a hydrogen atom, a nitrile radical or a C1-C4-alkyl radical or, together, a methylene or ethylene group, E a hydrogen atom or a C1-C4-alkyl radical, D and E together meaning a second bond between carbon atoms 1 and 2 or together a methylene group   <IMAGE> b)  or  <IMAGE> c)   with R11 in the meaning of a hydrogen atom or a C1-C8-alkyl radical, are described as well as their pharmaceutically tolerated addition salts with acids. The new compounds possess valuable pharmacological properties.
Patent JP-3532207-B2 (JP)
IPC: H04R17/00
Filed: 1994-06-21
Granted: 2004-05-31
Abstract: PCT No. PCT/FI94/00278 Sec. 371 Date Mar. 11, 1996 Sec. 102(e) Date Mar. 11, 1996 PCT Filed Jun. 21, 1994 PCT Pub. No. WO95/01079 PCT Pub. Date Jan. 5, 1995A folded dielectric film element is provided which converts energy. The film element includes at least one dielectric film that is bent into folds and provided with electrodes. The electrodes are arranged in the folds so that different electrodes are placed in successive folds. The strength of an electric field increases in one fold and decreases in a successive fold.
Patent JP-4445591-B2 (JP)
IPC: A01N33/18
Filed: 1996-06-05
Granted: 2010-04-07
Abstract: Herbicidal compositions comprising A) at least one compound from the group of the substituted phenylsulfonylureas of the formula I and their agriculturally acceptable salts in which R<SUP>1 </SUP>is (C<SUB>1</SUB>-C<SUB>8</SUB>)alkyl, (C<SUB>3</SUB>-C<SUB>4</SUB>)alkenyl, (C<SUB>3</SUB>-C<SUB>4</SUB>)alkynyl or (C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl which is mono- to tetrasubstituted by radicals selected from the group consisting of halogen and (C<SUB>1</SUB>-C<SUB>2</SUB>)alkoxy, and B) at least one herbicidally active compound from the group of compounds composed of Ba) herbicides which act selectively against grasses in cereals and/or maize, Bb) herbicides which act selectively against dicots in cereals and/or maize, Bc) herbicides which act selectively against grasses and dicots in cereals and/or maize and Bd) herbicides which act non-selectively against grass weeds and broad-leaved weeds in non-crop areas and/or selectively against grass weeds and broad-leaved weeds in transgenic crops.
Patent JP-3390430-B2 (JP)
IPC: C07K1/00
Filed: 1991-12-02
Granted: 2003-03-24
Abstract: A process for producing a derivatized immunoglobulin and conjugates prepared therewith are provided. The derivatized immunoglobulin is produced by introducing sulfhydryl groups in the Fc region of an immunoglobulin wherein the Fab portion of the immunoglobulin is not altered. The derivatized immunoglobulin is used to prepare conjugates with various detectable moieties wherein a controlled distance exists between the Fc region of the immunoglobulin and the detectable moiety. The conjugates are particularly useful for performing immunoassays, and exhibit improved longevity, specificity and sensitivity.
Patent JP-2983058-B2 (JP)
IPC: C12Q1/6897
Filed: 1990-03-02
Granted: 1999-11-29
Abstract: PCT No. PCT/EP90/00372 Sec. 371 Date Nov. 9, 1990 Sec. 102(e) Date Nov. 9, 1990 PCT Filed Mar. 2, 1990 PCT Pub. No. WO90/10074 PCT Pub. Date Sep. 7, 1990.The invention relates to use of the nitrate reductase gene as a selection marker in transformations of the antibiotic-producing species Penicillium chrysogenum and Acremonium chrysogenum. In particular it relates to a process for obtaining cells of Penicillium chrysogenum or Acremonium chrysogenum capable of expressing nitrate reductase from cells of the same species which are initially deficient in expression of the nitrate reductase gene (niaD-cells), which comprises introducing into said niaD-cells vector DNA including a marker gene coding for nitrate reductase operatively linked to a control sequence for expression of said gene within the selected host cells, followed by selection of cells thus transformed by their ability to grow on a suitable medium containing nitrate as the only source of nitrogen and to vector DNA for use in such a process.
Patent JP-2509774-B2 (JP)
IPC: C07K14/03
Filed: 1991-03-22
Granted: 1996-06-26
Abstract: A method of treating EBV infections is provided. The method comprises administering an effective amount of an monoclonal antibody antagonist to the EBV protein, BCRF1. Preferably, the antagonist is a blocking monoclonal antibody specific for BCRF1, or a fragment or binding composition derived therefrom.
Patent JP-2513929-B2 (JP)
IPC: B65B57/06
Filed: 1990-05-04
Granted: 1996-07-10
Abstract: Apparatus (5) that uses the burster method for positioning coupons from a continuous web (46) at a predetermined time at a predetermined location for insertion is disclosed. Positioning rolls (48, 50) define a bight to receive the leading edge of a coupon (20) and are driven by positioning drive mechanism (58) at a continuous predetermined speed. Feeding roll mechanism (36, 38) located upstream of the positioning rolls (48, 50) in the excess of one coupon length are driven by intermittent feeding drive (56) at a speed substantially less than the speed of the positioning rolls (48, 50). Controller (70) actuates and deactuates the feeding drive mechanism (56) in response to timing device (24, 26) related to the position of a container (10) and coupon sensing device (62) at a sensing position between the positioning rolls (48, 50) and the feeding roll mechanism (36, 38).
Patent JP-4232992-B2 (JP)
IPC: C07H21/04
Filed: 1997-08-15
Granted: 2009-03-04
Abstract: Engineered fluorescent proteins, nucleic acids encoding them and methods of use. <IMAGE> <IMAGE>
Patent JP-4160116-B2 (JP)
IPC: C01B33/36
Filed: 1996-09-13
Granted: 2008-10-01
Abstract: PCT No. PCT/AU96/00576 Sec. 371 Date Jun. 10, 1998 Sec. 102(e) Date Jun. 10, 1998 PCT Filed Sep. 13, 1996 PCT Pub. No. WO97/10179 PCT Pub. Date Mar. 20, 1997Novel magnesiosilicate compounds for use in detergent compositions and as water softeners have a calcium binding capacity of at least 10 mg CaO per gram, a magnesium binding capacity of at least 10 mg MgO per gram and a calcium binding rate of no more than 300 seconds, all at room temperature. The compounds have a stuffed silica polymorph-related structure or a layered structure with a broad X-ray powder diffraction peak at a d-spacing of between 11 and 17  ANGSTROM . The compounds have an anhydrous composition MaMgbAlcSi1-(b+c)Od, where M-alkali, 0.0<a<2.0, 0.0<b<0.7, 0.0</=c</=0.3, 1.15<d<3.0, c<b, and partial substitution of M, Mg, Al and Si is permitted. The compounds are prepared by solid state reaction or aqueous reaction of starting material such as magnesiosilicate mineral with alkali oxide-containing reagent under relatively mild conditions or by treating a magnesiosilicate compound having a stuffed silica polymorph-related structure with aqueous solution.
Patent JP-4130994-B2 (JP)
IPC: H04L27/26
Filed: 1997-09-01
Granted: 2008-08-13
Abstract: A multi-carrier transmission system using orthogonal carriers with high order QAM constellations for the transmission of multiple bits per carrier and symbol. Such systems place high demands on the synchronization of the receiver with the transmitter. The maximum permitted deviation from exact synchronization is usually a small fraction of a sampling interval. A reserve carrier, the pilot carrier, which is given a fixed phase, is usually used as the reference to achieve this high accuracy. The receiver sampling clock oscillator is phase locked to the pilot carrier. It is therefore necessary to estimate the phase of the pilot carrier. Using a bandpass filter to recover the pilot carrier, regardless of the frame structure of the DMT signal, does not eliminate the influence of neighboring carriers on the pilot carrier.
Patent JP-2781662-B2 (JP)
IPC: C07D/
Filed: 1993-11-12
Granted: 1998-07-30
Abstract: Substituted pyrazoles of formula (I), wherein R1, R2, R3, X, Y, Z and A are as defined herein, have corticotropin-releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.
Patent JP-3874024-B2 (JP)
IPC: C12N5/07
Filed: 1995-11-22
Granted: 2007-01-31
Abstract: PCT No. PCT/EP95/04589 Sec. 371 Date May 22, 1997 Sec. 102(e) Date May 22, 1997 PCT Filed Nov. 22, 1995 PCT Pub. No. WO96/15802 PCT Pub. Date May 30, 1996Hepatocyte growth factor stimulates proliferation and differentiation of hematopoietic cells, most preferably burst-forming unit-erythroid cells. The hepatocyte growth factor may be obtained from cells transformed with human gene sequences coding therefor. Pharmaceutical compositions useful to induce the proliferation and differentiation of hematopoietic cells may contain hepatocyte growth factor as an active principle in admixture with a suitable carrier. The pharmaceutical compositions may additionally contain stem cell factor as an active principle.
Patent JP-3397797-B2 (JP)
IPC: C08L43/04
Filed: 1996-10-18
Granted: 2003-04-21
Abstract: Curable compositions comprising stable, water dispersible, curable polymers containing sterically hindered alkoxylated silane groups and acid groups blocked by fugitive bases at 0.1 to 75 weight percent of the total composition and water at 99.9 to 25 weight percent of the total composition are taught herein, as well as methods for the use and manufacture thereof. Additional components, such as emulsifiers, buffers and thickeners are also taught. These compositions are useful as adhesives, sealants and paints. The compositions have improved properties including solvent resistance, adhesion, hardness, abrasion resistance and mar resistance.
Patent JP-2769391-B2 (JP)
IPC: C07C29/80
Filed: 1994-02-23
Granted: 1998-06-25
Abstract: The present invention is an improved process for the recovery of ethylene glycol from spent glycol generated in the manufacture of polyethylene terephthalate. The spent glycol typically consists of metal oxide catalyst residues, low molecular weight terephthalate oligomers, diethylene glycol and other trace impurities. The improved process of the present invention is based on the principle that elevating the temperature of the spent glycol increases the solubility of the low molecular weight oligomers so that the low molecular weight oligomers can be dissolved in the ethylene glycol and further that the spent glycol at an elevated temperature may be passed through an ion exchange bed to remove metal oxide catalysts, color forming impurities and other trace impurities.
Patent JP-3574455-B2 (JP)
IPC: A61P43/00
Filed: 1994-11-28
Granted: 2004-10-06
Abstract: PCT No. PCT/US94/13711 Sec. 371 Date Sep. 9, 1996 Sec. 102(e) Date Sep. 9, 1996 PCT Filed Nov. 28, 1994 PCT Pub. No. WO95/21186 PCT Pub. Date Aug. 10, 1995The present invention provides novel macrocyclic difluorostatone derivatives which are useful as antiviral agents. More specifically, these novel compounds are useful as inhibitors of retroviral proteases required for replication, particularly the HIV-1 and HIV-2 viral proteases, in the prevention or treatment of infection by the human immunodeficiency virus (HIV), and in the treatment of consequent pathological conditions such as the acquired immunodeficiency syndrome (AIDS) in mammals capable of being infected with HIV virus.
Patent JP-3176067-B2 (JP)
IPC: A63C10/10
Filed: 1995-02-24
Granted: 2001-06-11
Abstract: An engaging mechanism (900) or a snow board (12) which is longer in a direction along a major axis, comprises a latch (800) which substantially intersects the major axis and is turnable between an engaging position and a releasing position, and an engaging member (756). A cleat (902) comprises a finger side engaging member. (756) engageable with the engaging member (756), and a heel side engaging piece (770) engageable with the latch (680). Both ear pieces are adjusted and separated from each other substantially in a direction along a major axis of a shoe and are generally positioned in the shoe. Formed on a sole of the shoe are recess (936) which permits the finger side engaging member (756) to engage with the engaging member (756) for moving, and another recess (946) which permits the heel side engaging piece (770) to move so as to engage with the latch (680). Engagement between the engaging members and the engaged pieces is effected by a stepping-in action. The cleat is located in the recess of the sole of the shoe and higher than a surface of the snow board, so that malfunction of the engaging mechanism will not be caused by gripping on snow. <IMAGE>
Patent JP-4913270-B2 (JP)
IPC: A61K31/19
Filed: 1997-12-29
Granted: 2012-04-11
Abstract: Compositions and methods for the diagnosis and treatment of diseases that are associated with imprinting are provided. Such compositions and methods are useful in restoring a normal pattern of imprinting to cells. The compositions comprise pharmacological agents that are involved in imprinting and can be used in preventive and therapeutic methods to restore a normal pattern of imprinting. Such agents are capable of restoring a normal pattern of imprinting to cells. Further methods of the invention include means for identifying pharmacological compounds that exert their effect by restoring normal imprinting to abnormally imprinted chromosomes and genes. Additionally, the invention could also be used to identify new compounds that exert their effect by restoration of normal imprinting to diseased tissues that exhibit underlying abnormal imprinting.